Literature DB >> 17052710

Adapter protein NRBP associates with Jab1 and negatively regulates AP-1 activity.

Hui Wang1, Xiaoqing Sun, Ying Luo, Zhixin Lin, Jun Wu.   

Abstract

Jun activation domain-binding protein 1 (Jab1) is a coactivator of activating protein-1 (AP-1) and is the fifth component of the COP9 signalosome complex. It interacts with a variety of proteins and plays important roles in diverse signaling pathways and cellular function including oncogenesis. We show here that Jab1 interacts in vivo with nuclear receptor binding protein (NRBP), an evolutionarily conserved adapter protein with a kinase-like domain. We further show that NRBP inhibits Jab1-induced phosphorylation of c-Jun and AP-1 activation. Finally, overexpression of NRBP in mammalian cells specifically inhibits AP-1 activation by various stimuli. Taken together, our data suggest that NRBP may be an important negative regulator of Jab1-mediated functions such as gene transcription and tumor progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052710     DOI: 10.1016/j.febslet.2006.10.002

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Ligustilide Inhibits Tumor Angiogenesis by Downregulating VEGFA Secretion from Cancer-Associated Fibroblasts in Prostate Cancer via TLR4.

Authors:  Jing Ma; Xu Chen; Yumo Chen; Ning Tao; Zhihai Qin
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

2.  Madm (Mlf1 adapter molecule) cooperates with Bunched A to promote growth in Drosophila.

Authors:  Silvia Gluderer; Erich Brunner; Markus Germann; Virginija Jovaisaite; Changqing Li; Cyrill A Rentsch; Ernst Hafen; Hugo Stocker
Journal:  J Biol       Date:  2010-02-11

3.  CAPER, a novel regulator of human breast cancer progression.

Authors:  Isabelle Mercier; Donna M Gonzales; Kevin Quann; Timothy G Pestell; Alexander Molchansky; Federica Sotgia; James Hulit; Ricardo Gandara; Chenguang Wang; Richard G Pestell; Michael P Lisanti; Jean-François Jasmin
Journal:  Cell Cycle       Date:  2014-02-17       Impact factor: 4.534

4.  GATA binding protein 1 recruits histone deacetylase 2 to the promoter region of nuclear receptor binding protein 2 to affect the tumor microenvironment and malignancy of thyroid carcinoma.

Authors:  Mengyuan Li; Hongwei Jiang; Shengjiang Chen; Yujin Ma
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

5.  Nuclear receptor binding protein 1 correlates with better prognosis and induces caspase-dependent intrinsic apoptosis through the JNK signalling pathway in colorectal cancer.

Authors:  Yi Liao; Zihuan Yang; Jintuan Huang; Hao Chen; Jun Xiang; Senmao Li; Chunyu Chen; Xuan He; Feng Lin; Zuli Yang; Jianping Wang
Journal:  Cell Death Dis       Date:  2018-04-01       Impact factor: 8.469

6.  High NRBP1 expression promotes proliferation and correlates with poor prognosis in bladder cancer.

Authors:  Qi Wu; Xiaoqing Zhou; Peng Li; Wei Wang; Jun Wang; Mingyue Tan; Le Tao; Jianxin Qiu
Journal:  J Cancer       Date:  2019-07-10       Impact factor: 4.207

7.  NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer.

Authors:  Zhiyu Li; Bingxiong Liu; Chenyuan Li; Si Sun; Hanpu Zhang; Shengrong Sun; Zhong Wang; Xiongjie Zhang
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

8.  Synergistic Effects of Genetic Variants of Glucose Homeostasis and Lifelong Exposures to Cigarette Smoking, Female Hormones, and Dietary Fat Intake on Primary Colorectal Cancer Development in African and Hispanic/Latino American Women.

Authors:  Su Yon Jung; Eric M Sobel; Matteo Pellegrini; Herbert Yu; Jeanette C Papp
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.